Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Subst Abuse Treat. 2021 Jun 24;131:108546. doi: 10.1016/j.jsat.2021.108546

Table 1 –

Characteristics of Medicaid population, Medicaid population with opioid overdose, and prevalence of overdose in Medicaid population.

Medicaid Population, Totala (%) Individuals with Opioid Overdose (%) Within Group, Opioid Overdose Rate per 100,000 Person-Years

Covariate 2014 N = 630,009 2019 N = 717,585 2014 N = 661 2019 N = 2,269 2014 N = 630,009 2019 N = 717,585

Overall 120.5 426.8

Age
 12–24 42.8 42.2 11.2 5.3 31.2 60.4
 25–39 25.9 24.7 39.3 41.8 178.4 712.3
 40–55 22.5 21.3 36.6 37.3 195.2 723.5
 56–64 8.8 11.7 12.9 15.6 192.4 605.7

Racial/Ethnic Group
 White 37.1 37.7 59.6 55.8 191.0 628.4
 Black 26.3 24.4 22.7 27.9 104.8 501.4
 Hispanic 16.4 23.3 10.7 11.2 61.1 198.7
 Other/Unknown 20.2 14.7 7.0 5.2 59.1 147.4

Gender
 Female 58.2 56.9 44.6 38.3 90.0 283.2
 Male 41.8 43.1 55.4 61.7 162.9 616.8

SUD Comorbidities
 Alcohol Use Disorder 2.5 3.4 33.9 39.0 1821.1 5340.8
 Cannabis Use 1.5 2.6 15.9 26.5 1346.9 4774.4
 Benzodiazepine Use Disorder 0.3 0.6 14.5 21.4 7396.3 17603.9
 Opioid Use Disorder 2.4 5.1 71.0 86.2 3634.8 7451.6

Psychiatric
 Schizophrenia 1.7 2.1 12.0 11.5 875.4 2435.6
 Bipolar Disorder 3.1 3.8 30.6 28.0 1218.5 3290.5
 Major Depression 3.7 10.5 29.3 50.9 997.6 2101.2

Medical Comorbidities
 HIV 1.5 1.1 5.1 5.6 600.5 2256.1
 Hepatitis C 1.4 2.1 23.9 30.0 2212.3 6503.1
 Diabetes 11.6 15.6 20.7 30.1 237.0 926.4
 Heart Failure 1.4 1.5 13.9 8.6 1245.6 2598.4
 Cerebrovascular Disease 1.8 2.0 9.8 7.6 835.7 1725.7
 Chronic Pain Diagnosis 11.6 12.6 31.6 30.4 352.5 1119.2
 Asthma 10.4 6.4 29.0 12.3 334.2 880.2
 COPD 0.9 2.4 8.8 14.7 1337.1 2790.9
 Pneumonia 1.5 1.8 19.5 16.0 1720.3 4350.5
 Sleep Apnea 2.3 3.3 4.7 3.4 250.3 429.6
a

Includes the full Medicaid population meeting study inclusion criteria.